Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multi-dose Oral Ondansetron for Pediatric Gastroenteritis
NCT03851835Phase 3Completed
- Sponsor
- University of Calgary
- Start
- Sep 2019
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ondansetron in acute gastroenteritis and Vomiting, sponsored by University of Calgary. Primary endpoint: Modified Vesikari Scale at 168 hours. Started Sep 2019; status: completed.
02
Drugs
ondansetron
03
Conditions
acute gastroenteritisVomiting
Beyond the preview
Go deeper on NCT03851835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03851835.